Skip to main content
Premium Trial:

Request an Annual Quote

Fujirebio, Sysmex Ink Reagent Raw Material Supply Deal

NEW YORK — Fujirebio and Sysmex said on Thursday that they have signed a reagent raw material supply agreement that builds on a recently formed immunoassay assay development alliance between the Japanese companies.

In October, Fujirebio and Sysmex agreed to collaborate on the development of immunoassays that run on Sysmex's HISCL-Series automated system, with the goal of moving into an execution phase by early 2024.

In support of that deal, the companies last month struck a contract development and manufacturing organization (CDMO) agreement related to the development of reagents for cerebrospinal fluid-based and blood-based testing for neurodegenerative diseases including Alzheimer's disease.

Under that latest agreement, Fujirebio and Sysmex will both supply a range of reagent materials, primarily antigens and antibodies, to support the CDMO deal.

Additional terms were not disclosed.